本页面由Tiger Trade Technology Pte. Ltd.提供服务

Vincera Pharma, Inc.

0.0127
0.0000-0.39%
成交量:507.00
成交额:6.44
市值:6.65万
市盈率:0.00
高:0.0127
开:0.0127
低:0.0127
收:0.0128
52周最高:1.43
52周最低:0.0002
股本:523.43万
流通股本:494.05万
量比:0.12
换手率:0.01%
股息:- -
股息率:- -
每股收益(TTM):-8.9799
每股收益(LYR):-15.8451
净资产收益率:-3136.43%
总资产收益率:-197.53%
市净率:0.03
市盈率(LYR):0.00

数据加载中...

2025/07/07

重要事件披露

Form 8-K - Current report
2025/05/16

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/05/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/05/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/05/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/05/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/04/29

自愿退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2025/04/17

重要事件披露

Form 8-K - Current report
2025/04/11

重要事件披露

Form 8-K - Current report
2025/03/31

SEC问询函

Form CORRESP - Correspondence
2025/03/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/18

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/03/18

重要事件披露

Form 8-K - Current report
2025/02/28

重要事件披露

Form 8-K - Current report
2025/02/19

重要事件披露

Form 8-K - Current report
2025/02/07

SEC问询函

Form CORRESP - Correspondence
2025/02/06

重要事件披露

Form 8-K - Current report
2025/01/23

重要事件披露

Form 8-K - Current report
2025/01/23

重要事件披露

Form 8-K - Current report